Literature DB >> 2905934

Evidence for the involvement of the benzodiazepine receptor complex in hepatic encephalopathy. Implications for treatment with benzodiazepine receptor antagonists.

A S Basile1, S H Gammal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2905934     DOI： 10.1097/00002826-198810000-00002

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  5 in total

1.  Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy.

Authors:  U Wysmyk; S S Oja; P Saransaari; J Albrecht
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

Review 2.  DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications.

Authors:  M L Barbaccia; A Berkovich; P Guarneri; E Slobodyansky
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

3.  Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.

Authors:  C C van der Rijt; R J de Knegt; S W Schalm; O T Terpstra; K Mechelse
Journal:  Metab Brain Dis       Date:  1990-09       Impact factor: 3.584

Review 4.  Flumazenil in the treatment of portal systemic encephalopathy--an overview.

Authors:  K Gyr; R Meier
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

5.  Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy.

Authors:  A S Basile; L Pannell; T Jaouni; S H Gammal; H M Fales; E A Jones; P Skolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.